Deutsche Bank upgraded CVS stock to buy, with a $66 price target, expecting a 12% upside. Analysts believe CVS is poised for a recovery due to strong leadership changes and growth efforts, especially in the managed care organizations segment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing